About Us: Faculty & Staff

Director

Eva L. Feldman, M.D., Ph.D.
Professor of Neurology

Eva Feldman, MD, Ph.D

Eva L. Feldman, M.D., Ph.D., is a professor of neurology at the University of Michigan Health System. She has authored more than 129 articles and 48 book chapters covering a spectrum of issues in the diagnosis and treatment of patients with neurological diseases. Dr. Feldman's current investigative activities emphasize an understanding of the pathogenesis and treatment of neuromuscular disorders with an emphasis on diabetic neuropathy and Amyotrophic Lateral Sclerosis (ALS). At the University of Michigan Health System, she serves as Director of the Juvenile Diabetes Research Foundation Center for the study of complications in diabetes and of the ALS clinic and research. Dr. Feldman is listed in Best Doctors of America, serves as the neurologist for the Diabetes Program of the National Institutes of Health, and is on several editorial boards, NIH review panels and study sections. Dr. Feldman has served as a mentor for 23 postdoctoral research fellows, 26 clinical neuromuscular fellows and seven neuroscience graduate students. Her work is supported by two RO1 grants from the National Institutes of Health, and grants from the American Diabetes Association, Juvenile Diabetes Foundation and the ALS Association. Dr. Feldman received her M.D. and Ph.D. from the University of Michigan, completed a neurology residency at the Johns Hopkins Hospital where she served as Chief Resident, and completed a fellowship in clinical neuromuscular disease at the University of Michigan.

Faculty

Norman D. Hogikyan, M.D., F.A.C.S.
Director, Vocal Health Center
Associate Professor of Otolaryngology-Head and Neck Surgery
Associate Professor of Music University of Michigan

Dr. Hogikyan

Dr. Hogikyan’s clinical and academic interests are in the human voice, voice disorders and laryngeal surgery. His basic science research has been in the area of laryngeal reinnervation, and his clinical research has focused in the measurement of voice-related quality of life. Dr. Hogikyan graduated from the University of Michigan magna cum laude with highest distinction in Cellular and Molecular Biology. He went on to medical school at the University of Michigan and graduated cum laude with distinction in research. While in medical school, Dr. Hogikyan was awarded a prestigious Howard Hughes Medical Institute-National Institutes of Health Research Scholar fellowship to work at NIH in a molecular genetics laboratory. He went on to complete his residency in Otolaryngology-Head and Neck Surgery at Washington University in St. Louis, and a fellowship in Laryngology with Dr. Robert Bastian at Loyola University of Chicago. He joined the faculty of the University of Michigan in 1995. Dr. Hogikyan and colleagues in Otolaryngology have a well-established collaboration with the Feldman laboratory in the study of laryngeal paralysis and exploration of the use of gene therapy in regeneration of injured laryngeal nerves.

Nicholas Boulis, M.D.
Adjunct Assistant Professor of Neurology

Dr. Boulis
Dr. Nicholas Boulis, neurosurgeon at the Cleveland Clinic Center for Neurological Restoration, is a physician scientist whose research interests include biological neurorestoration and neuromodulation through the use of cell, protein, and gene delivery to the nervous system. Dr. Boulis graduated summa cum laude from Yale University with distinction in the intensive Biology and Philosophy majors. He graduated magna cum laude from Harvard Medical School winning the Harold Lamport Biomedical Research Award. Dr. Boulis has developed a clinical program focusing on peripheral nerve regeneration, spasticity, pain and Parkinson's Disease. He applies advanced microsurgical, radiosurgical, as well as ablative and neural augmentation approaches. He is currently working on strategies for gene based motor neuron protection for ALS, neural targeting of gene delivery, and gene-based neuromodulation. He collaborates with Nicholas Mazarakis, Ph.D., of Oxford Biomedica as well as Michael Imperiale, PhD. and Eva Feldman, M.D., Ph.D., at the University of Michigan in the field of ALS gene therapy. His work on neural targeting of biological therapies involves an active collaboration with Tom Brown, Ph.D., of Massachussetts General Hospital. Finally, his lab collaborates with Imad Najm, M.D., (CCF) on epilepsy neuromodulation,T Subramanian, M.D., (CCF), on Parkinson's neuromodulation, and Michael Davis, Ph.D., (Emory), on anxiety neuromodulation. In the last year, Dr. Boulis has presented his work at the American Society for Gene Therapy, Society for Neuroscience, The Congress of Neurological Surgeons, and The American Association of Neurologic Surgeons. He is the author of 46 publications. For the past seven years, Dr. Boulis has independently organized and secured funding for an outreach/teaching mission to provide surgical therapy to patients in Guatemala requiring treatment for hydrocephalus and spina bifida. To date, "Project Shunt" has provided 186 free operations to impoverished Guatemalan children. Dr. Boulis is an integral member of the Center's innovative neurosurgical team, equally skilled in clinical and laboratory settings.

Kelli A. Sullivan, Ph.D.
Assistant Research Professor

Dr. Sullivan

Kelli Sullivan, Ph.D., is an assistant research scientist in the Department of Neurology. Dr. Sullivan received her Ph.D. from the Department of Anatomy and Neurobiology at the University of Kentucky and completed a first postdoctoral fellowship at Columbia University, College of Physicians and Surgeons. Dr. Sullivan joined Dr. Feldman as a postdoctoral fellow in 1993. She has authored or co-authored 19 research articles and three book chapters on development and disease models in the nervous system. Her current research focuses on the effects of diabetes on growth factor production within peripheral nerves and the effects of diabetes on small myelinated and unmyelinated axons within human sural nerves. She is Director of the Juvenile Diabetes Research Foundation Center Morphology Core Facility. Dr. Sullivan is also interested in the developmental expression of IGF-I in the spinal cord and its application to traumatic spinal cord injury.

Bhumsoo Kim, Ph.D.
Assistant Research Professor
Dr. Kim

Bhumsoo Kim, Ph.D., is a research investigator in the Department of Neurology. Dr. Kim received his Ph.D. in the Neuroscience Program from the University of Michigan with Dr. Feldman. He was awarded an Outstanding Student Publication Award from the Neuroscience Program and a Young Investigator Education Enhancement Award from the American Society for Neurochemistry. He completed his post-doctoral fellowship at the Joslin Diabetes Center of Harvard University before returning to Dr. Feldman's laboratory. Dr. Kim has authored or co-authored 18 research articles. His current research focuses on the regulation of IGF-I signaling molecules in neuronal cells and the relationship between diabetes and Alzheimer's disease. The incidence of both diabetes and Alzheimer's disease are increasing rapidly in the United States and there are strong evidences that diabetes is a risk factor for Alzheimer's disease. Dr. Kim is specifically interested in the regulation of the proteins involved in Alzheimer's disease by IGF-I in diabetic conditions.

Andrea Vincent, Ph.D.
Assistant Research Professor

Dr. Vincent

Andrea Vincent, Ph.D., is an Assitant Research Professor in Neurology.  She completed her doctorate at the University of Liverpool, United Kingdom in Cell Biology before moving to the United States to focus her research interests on neurological disease.  Her current research interests focus on the role of oxidative stress in neurodegenerative disorders.  She previously examined how reactive nitrogen species contribute to stroke-induced brain injury.  Dr. Vincent is now mapping oxidative stress pathways in the peripheral nervous system in diabetes and developing therapeutic strategies against these mechanisms.  She developed a drug screening paradigm that she used first for an cell culture model of amyotrophic lateral sclerosis and then adapted for diabetic neuropathy.  The results of a primary screen of 1040 FDA-approved compounds was recently published and the lead compounds are being tested in pre-clinical trials of diabetic neuropathy in mice.  Dr. Vincent hopes to obatin NIH funding to continue this ground-breaking work to develop a treatment for this disease.  Her assay development expertise is utilized in her directorship of the JDRF Oxidative Stress Core.

Hsinlin Thomas Cheng, M.D., Ph.D.
Assistant Professor of Neurology and Anesthesia

Cheng

Dr. Cheng is an Assistant Professor of Neurology and Anesthesia.  He is board certified in Neurology and Pain Medicine.  Dr. Cheng graduated from Taipei Medical College.  He received his Ph.D. from the Neuroscience Program of the University of Michigan under the mentorship of Dr. Feldman.  Dr. Cheng had his Neurology residency training at the Wayne State University.  He also finished the subspecialty training at the Pain and Palliative Care Program of the Memorial Sloan Kettering Cancer Center and a research fellowship in Pain Medicine at the Weill Medical College of Cornell University.

 Dr. Cheng returned to University of Michigan as a faculty in 2006.  Currently, He treats patients with a variety of pain syndromes, including painful diabetic neuropathy, at the Back and Pain Center of the University of Michigan.  In the laboratory, he uses animal models of type 1 and type 2 diabetes to study the molecular and signaling events that mediate DNP.  His goal is to determine the key molecules for the development of DNP.  By identifying these key elements, mechanism-specific treatments will then be developed.   Dr. Cheng is the primary author or coauthor of 17 peer-reviewed articles.  Dr. Cheng works closely with Dr. Feldman and other scientists of PNR&D to study DNP.  He has presented his work at the annual conferences of the American Pain Society and the Society for Neuroscience.         

Joseph Corey, M.D., Ph.D.
Research Fellow / Assistant Professor

Dr. Corey

Joseph Corey, M.D., Ph.D., is a lecturer in the Department of Neurology. Dr. Corey received his M.D. and Ph.D. in Neuroscience from the University of Illinois(Urbana). For his doctoral research, he developed technologies to pattern cultured neurons into circuits. He also earned an MS in biomedical engineering for Case Western Reserve University where he worked on neural prostheses. He has authored or co-authored seven publications. His research interests center on development and repair in the nervous system, as well as tissue engineering. His clinical interests are in recovery from neurologic insult and restorative technologies for the disabled. Dr. Corey was awarded a Mentored Clinical Scientist Development Award from the NIH to study ways of making better scaffolds for nerve regeneration.

Adam Rubin, M.D.
Director, Lakeshore Professional Voice Center

Dr. Rubin

Adam Rubin, M.D., graduated summa cum laude from Yale College with degrees in Theater Studies and Economics. He received his medical doctorate from Harvard Medical School. Following his residency in Otolaryngology-Head and Neck Surgery at the University of Michigan, he completed a fellowship in Laryngology and Care of the Professional Voice under the direction of Robert T. Sataloff, M.D., D.M.A., in Philadelphia. Prior to specializing in Laryngology, Dr. Rubin enjoyed a life-long passion for the human voice. Before attending medical school, he was a professional actor and singer, performing in musicals, and plays at off-Broadway and regional theaters, as well as in a national tour. He is also an accomplished rock and roll singer, and a classical violinist. Dr. Rubin’s basic science interests include viral gene therapy and laryngeal nerve regeneration. He began his collaboration with Dr. Feldman and the PNR&D as a resident, during which time he received the University of Michigan Merle Lawrence Basic Science Research and the John L. Kemink Clinical Research Awards. He currently practices at Lakeshore Ear, Nose and Throat Center in St. Clair Shores where he is Director of the Lakeshore Professional Voice Center, and is thrilled to continue working with the PNR&D.

Rodica Pop-Busui, M.D., Ph.D.
Assistant Professor of Internal Medicine

Rodica Pop-Busui, M.D., Ph.D., is an assistant professor in the Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes at the University of Michigan. She is actively involved in both basic-translational and clinical research in diabetes and diabetes complications, with a focus on diabetic autonomic and peripheral neuropathy. Dr. Pop-Busui's basic research project concerned with the role of Cycooxygenase-2 activation and oxidative stress in peripheral nerve dysfunction in diabetes is funded the National Institutes of Health. She is principal investigator in multiple clinical trials funded by National Institutes of Health, Juvenile Diabetes Research Foundation and Industry. Dr. Pop-Busui is a recipient of a Fulbright Award in 1995, American Diabetes Association Endocrinology Fellow of Excellence Award in 2001 and of the University of Michigan Clinical Science Scholar Award in 2005. She serves as member of the Council for Clinical Research of the American Association of Clinical Endocrinologists and of the Peer Review Committees of the American Heart Association. Dr. Pop-Busui received her M.D. and Ph.D. summa cum laude at the University of Timisoara in Romania. After completing internal medicine training and obtaining board certification in Internal Medicine in Romania, she completed postgraduate training in diabetes at the Royal Hallamshire Hospital in Sheffield UK and a Fellowship in Endocrinology and Metabolism at the University of Michigan and joined the faculty of the University of Michigan in July 2005. She has authored peer-reviewed articles and book chapters related to diabetes, diabetic autonomic and peripheral neuropathy and diabetes complications.

Stephen I. Lentz, Ph.D.
Laboratory Director / Research Investigator

Dr. Lentz

Stephen I. Lentz, Ph.D., is a research investigator in the Division of Metabolism, Endocrinology and Diabetes of the Department of Internal Medicine. Dr. Lentz is also the Laboratory Director of the Morphology and Image Analysis Core in the Michigan Diabetes Research and Training Center. He actively collaborates with Dr. Feldman's laboratory in their studies of diabetic neuropathy. Current research uses high resolution confocal microscopy to examine the effects of high glucose on mitochondrial dynamics in sensory neurons. Dr. Lentz received his Ph.D. in the Cellular and Clinical Neurobiology from Wayne State University. He completed a postdoctoral fellowship at Washington University in St. Louis, MO, investigating the effects of growth factors on peripheral nerve outgrowth. He came to the University of Michigan in 1998 and has served as the Laboratory Director of the Morphology Core since 2001. He has authored or co-authored 15 peer-reviewed research articles.

James Dowling, M.D., Ph.D.
Clinical Lecturer, Department of Pediatrics and Communicable Diseases
Co-Director, Muscular Dystrophy Association/Pediatric Neuromuscular Clinic

Dr. Dowling

Jim Dowling, M.D., Ph.D., is a lecturer in the Division of Child Neurology in the Department of Pediatrics. Dr. Dowling received his M.D. and Ph.D. degrees from the University of Chicago. His doctoral research, performed in the laboratory of Dr. Elaine Fuchs, Ph.D., focused on the role of integrins in epidermal and neuronal development. He performed his clinical fellowship at the Children's Hospital of Philadelphia. His research efforts are focused on understanding and treating childhood muscle diseases. He is currently using the zebrafish model system to study Myotubular Myopathy and Congenital Myotonic Dystrophy, two severe myopathies of infancy that have no cure or modifying treatments. He has authored or co-authored 19 publications. He is also the Co-Director of the University of Michigan’s Muscular Dystrophy Association/Pediatric Neuromuscular Clinic.

Fellows

James Edwards, Ph.D.
Postdoctoral Fellow

Dr. Edwards

James Edwards, Ph.D., is a postdoctoral research fellow who completed his Ph.D. in Chemistry from the University of Michigan. For his dissertation, Jim developed metabolomic technologies using separations and mass spectrometry for analysis of islets and bacteria. He has authored/co-authored seven peer reviewed articles. His research interest is in the role of hyperglycemia as it relates to neuronal cell death. In particular, his focus is on elucidating the pathways which induce mitochondrial dysfunction, with an ultimate goal of opening new avenues of therapeutic approach to diabetic neuropathy.

Claudia Figueroa-Romero, Ph.D.
Postdoctoral Fellow

Dr. Figueroa-Romero

Claudia Figueroa-Romero, Ph. D. is a postdoctoral research fellow who received her Ph. D from the Department of Biological Chemistry at the University of Michigan in the laboratory of Anne B. Vojtek. Her thesis reserch on the regulation of the Ras Trafficking and Ras Signaling was awarded with the Dziewiatkowski Award given to the most outstanding Ph.D. dissertation in the Department of Biological Chemistry. Dr. Figueroa-Romero continued her postdoctoral training in Dr. Vojtek’s lab characterizing the binding between the scaffold protein POSH and the serine/threonine kinase Akt2 and the biological significance of this interaction as regulator of the JNK signaling pathway. Dr. Figueroa-Romero joined the Feldman lab in 2007. Her current research focuses on identifying regulatory mechanisms, triggered by hyperglycemia, of molecules important for mitochondria biogenesis. This research will contribute to our understanding of the molecular players involved in diabetic neuropathy.

Simon Lunn, Ph.D.
Postdoctoral Fellow

Dr. Lunn

Simon Lunn, Ph.D., received his Ph.D. from the University of Dundee, Scotland, UK in 2005. His doctoral work was carried out in the Department of Cell and Developmental biology under the mentorship of Dr. Kate Storey. There, Dr. Lunn investigated the role of growth factor signals crucial in the first steps during the formation of nervous system during development. Dr. Lunn then moved to the United States to pursue his postdoctoral work. Dr. Lunn’s research interests focus on the mechanisms of neurological disease. Current research focuses on developing effective treatments for Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis or ALS. Dr Lunn uses models for ALS developed in the Feldman laboratory that allow him to investigate neuron disease and the role of growth factors such as IGF and VEGF that may provide vital neuroprotective properties for motor neuron survival. Dr. Lunn is part of the Stem Cell Initiative. Dr Lunn works closely with collaborators at the UCSD to understand the potential therapeutic application of stem cells in ALS.

Matthew Old, M.D.
Fellow/Resident, Department of Otolaryngology - Head & Neck Surgery

Dr. Old

Matthew Old, M.D. is a resident in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. He is participating in a research fellowship during the 2006-2007 academic year exploring neural regeneration patterns as well as the effects of viral gene therapy with neurotrophic factors in recurrent laryngeal nerve injury and facial nerve injury with Dr. Feldman and Dr. Hogikyan. Matt completed his undergraduate degree at Stanford University and his medical school training at the University of Texas-Houston Medical School. Dr. Old will complete his residency in June of 2008.

Catrina Robinson, Ph.D.
Postdoctoral Fellow

Robinson

Catrina Robinson, Ph.D., is a postdoctoral research fellow who received her Ph.D. in Pharmaceutical Sciences with a specialization in Pharmacology/Toxicology from Auburn University in 2007. For her doctoral research, Robinson characterized the modulation of Polysialic Acid on glutamatergic synaptic transmission. During her graduate work, Robinson earned numerous recognitions for academic excellence and merit including “Outstanding Graduate Student” and the honor of being the “Graduation Marshal” for the Harrison School of Pharmacy. As a postdoctoral research fellow, she was awarded a position on the Neurology Training Grant. Robinson current research interest involves oxidative stress in aging and the neuromuscular system. Robinson is also interested in the relationship between diabetes and Alzheimer’s disease and the role that lysosomal dysfunction play in protein accumulation associated with AD-neuropathology

Mahdieh Sadidi, Ph.D.
Postdoctoral Fellow

Dr. Sadidi

Mahdieh Sadidi, Ph.D., is a postdoctoral research fellow who received her Ph.D. in cellular and clinical neurobiology from the Wayne State University. While doing her doctorate work, Dr. Sadidi was awarded a Robert J. Bernucci Fellowship for research and academic excellence. She has research experience in protein chemistry, protein analysis, and the post-translational modifications of proteins under oxidative/ nitrosative stress. Her research interests include understanding the underlying signaling mechanisms that are affected by oxidative stress in disease as well as studying the role of antioxidants in disease prevention. Dr. Sadidi's research goal is to use proteomic techniques, in order to develop early biomarkers of diabetic complications that lead to earlier therapeutic intervention and establishment of a higher patient quality of life.

Stacey Sakowski, Ph.D.
Postdoctoral Fellow

Dr. Sakowski

Stacey Sakowski, Ph.D., is a postdoctoral research fellow who received her Ph.D. in Molecular Biology & Genetics from Wayne State University in 2006. During her graduate work, Dr. Sakowski was awarded the Graduate Professional Fellowship and a position on the Psychiatry Training Grant and her graduate research training focused on the biochemical characterization and analysis of posttranslational modifications of proteins. As a research fellow, Dr. Sakowski was awarded a position on the Neurology Training Grant. Her current research interests involve studying the mechanisms that are associated with motor neuronopathies such as Amyotrophic Lateral Sclerosis (ALS). Dr. Sakowski’s goals are to identify the responsible signaling pathways in motor neuron degeneration associated with ALS and to characterize the efficacy and mechanisms of treatment by growth factors such as VEGF and IGF-1. Dr. Sakowski is the author/co-author of five papers.

Adam Schuyler, Ph.D.
Postdoctoral Fellow

Dr. Schuyler

Adam Schuyler, Ph.D., is a postdoctoral research fellow who completed his Ph.D. in Mechanical Engineering from Johns Hopkins University. For his doctoral research, Adam developed computational models for studying the dynamics of proteins. He has authored/co-authored five peer reviewed articles. His research interest is in the continued development of multi-scale computational models. These models are used in conjunction with experimental findings and aid in the search for disease mechanisms.

Staff

Carey Backus
Research Associate II

Carey Backus joined Dr. Eva Feldman's laboratory in 2001. She received her BA in Molecular and Cell Biology from UC Berkeley in 1991, and then worked at UCSF in a developmental neurobiology lab. She manages the day to day operations of the lab, and works both independently, and together with other research investigators in Dr. Feldman's lab, to assist in ongoing research into mechanisms of apoptosis in disease models of the nervous system. She cultures primary rat sensory and motor neurons, which are used as in vitro models for diabetes and ALS. She performs biochemical assays and immunocytochemistry. She phenotypes different mouse models of diabetes with various techniques, including nerve conduction velocity testing of both sensory and motor nerves.

Lisa L. Baiz
Research Assistant I

Lisa Baiz

Lisa Baiz is a Research Assistant I in the Department of Neurology. She is currently involved in three ongoing clinical trial studies taking place at the University of Michigan, along with other sites across the nation. She does data entry for the IGF-I study, which is for people with ALS, the IGTN study, which is for glucose intolerance and neuropathy and the JDRF study for diabetic neuropathy. Most of her time is dedicated to the IGF-I study where, along with data entry, she also works with Dr. Feldman and the research team in all aspects of the clinical trial.

Judith Boldt, B.B.A.
Executive Assistant

Boldt

Judith Boldt  is executive assistant to Dr. Feldman, responsible for grant and manuscript submissions, as well as daily correspondence and administrative activities for the Taubman Institute and the Program for Neurology Research and Discovery laboratory.  Boldt also assists Dr. Feldman in her work on  the Juvenile Diabetes Research Foundation Center for the Study of Complications in Diabetes.  Ms. Boldt received a Bachelor of Business Administration degree from Eastern Michigan University in 2005. 

 

Elizabeth Gibbs
Ph.D. Candidate in Neuroscience

Gibbs

Elizabeth Gibbs received a B.A. in Biochemistry, Biophysics and Molecular Biology from Whitman College in Walla Walla, WA. Her research focuses on the cellular mechanisms underlying inherited neuropathies and myopathies, particularly the role of membrane trafficking pathways. She is currently looking at muscle development and maintenance abnormalities in zebrafish models of myopathy.

 

John Hayes
Research Assistant II

John Hayes

John Hayes received a bachelors degree in psychology and pre-medical studies from Oakland University in 1999. He joined the laboratory in the spring of 2000 to assist in ongoing research within the Juvenile Diabetes Research Foundation Center for the Complications in Diabetes. Mr. Hayes performs immunohistochemistry, in situ hybridization, transmission electron microscopy, scanning electron microscopy, confocal microscopy, nerve conduction studies, analgesia testing and animal dissections. Mr. Hayes also works with the Animal Models of Diabetic Complications Consortium characterizing diabetic neuropathy in mice.

Yu Hong
Research Associate I

Yu Hong

Yu Hong received her MS in Molecular Biology from University of
Maryland at College Park. In 2002, she worked at Biotherapies Inc. and
Pfizer Inc., studying a growth inhibitor of breast cancer and using
siRNA technology to silence a lipoprotein candidate gene involved in
cardiovascular disease. In 2003, she joined the program for PNRD at
University of Michigan. Her current efforts involve investigating gene
regulatory profiles for Amyotrophic lateral sclerosis (ALS) disease and
Diabetes.

Junguk Hur
Ph.D. Candidate in Bioinformatics

Hur

Junguk Hur received a B.S. in life science from Pohang University of Science and Technology in Korea and a master’s degree in bioinformatics from Indiana University, Bloomington. His primary research area is literature mining and information retrieval which aims at identifying targets (genes and proteins) from vast amount of context specific biomedical literatures. He has developed JUMiner, which is a web-based user-friendly literature mining tool that can be used on any topic of users’ interest. He is also working to discover new molecular targets for diabetes treatment through high-throughput microarray analysis and literature mining.

Aaron Kellogg
Assistant in Research

Aaron Kellogg received a Bachelors degree in Biochemistry from Case Western Reserve University in 2001. He joined Dr. Rodica Pop-Busui’s lab at the Medical College of Ohio in 2002 and followed her to the University of Michigan in 2005. Mr. Kellogg performs immunohistochemistry, oxidative stress analysis, prostaglandin production analysis, nerve conduction studies, analgesia testing, and animal dissections.

Lisa McLean
Research Associate I

Lisa McLean

Lisa McLean joined the Oxidative Stress Core in April 2001 to assist in ongoing research within the Juvenile Diabetes Research Foundation Center for the Study of Complications in Diabetes. Ms. McLean performs assays to determine oxidative stress damage found in tissue, cells, plasma and urine. She came from the UM SPORE for Prostate Cancer Program where she was involved in developing and characterizing animal models of prostate cancer.

Sang Su (Alex) Oh
Research Technician Intermediate

Sang Su Oh

Originally from South Korea, Alex moved to the United States in November 2003 to join the laboratory and gain hands-on research experience in the field of neurology. Alex received his D.V.M. in 2001 at Konkuk University and his masters of neuroscience degree in February 2003 at Ajou University . He works directly with senior staff members to investigate cell-signaling pathways implicated in neuroblastoma. Alex performs cell culture, protein analysis, immunocytochemistry, Western blotting, adhesion assays and migration assays on a regular basis. In addition, he is responsible for maintaining laboratory supplies and solutions.

Stephanie Peterson
Major and Planned Gift Officer

Stephanie Peterson

Stephanie Peterson is a major gift officer in the University of Michigan Health System who became involved with PNR&D (Program for Understanding Neurological Diseases) fundraising activities in late 2000. Her current work entails initiating and coordinating major and planned gifts from individuals in support of PNR&D research. In addition, Ms. Peterson solicits sponsorships for events from companies and groups like Pepsi Bottling Group and the Executive Women’s Golf Association. Prior to coming to PNR&D, she worked at MCARE in the Partnership Health program. Ms. Peterson has a Bachelor of Science from the University of Michigan.

Kathleen Ryan
Clinical Subjects Coordinator (Clinical trials)

Kathleen Ryan

Kathleen Ryan, R.NCS.T. is a Clinical Subjects Coordinator in the Department of Neurology. She spent 7.5 years in the Radiation Oncology department of the University of Michigan coordinating cancer clinical trials. She conducted these trials both at UM hospital and at several UM off site facilities where she worked independently. Her current investigative activities center on the coordination of new and ongoing clinical research studies. The studies include patients with neuropathy associated with diabetes, ALS, impaired glucose tolerance and cardiac autonomic neuropathy. Ms. Ryan is a registered technician (R.NCS.T.) with the American Association of Electrodiagnostic Technologists (AAET). She works with Drs. Eva Feldman and Rodica Pop-Busui at the University of Michigan.

Mindy Waite
CMB Graduate Student

Waite

Mindy grew up in Madison, Wisconsin and earned her B.S. in Genetics there.  Her undergraduate work focused on the HDAC inhibitor, TSA, and its effects on chromatin in immortalized mouse cells.  Under Dr. Feldman’s guidance here at the University of Michigan, she is studying the link between ALS and autophagy, using the zebrafish as her model system.  Because ALS is a fatal neurodegenerative disease, knowing the existence and strength of such a link is an important first step towards prevention and possibly treatment.

 

Tim Wiggin
Research Tech Intermediate

Tim Wiggin

Tim Wiggin recieved a B.S. in Cell and Molecular Biology from the University of Michigan in 2004 and a master's degree in bioinformatics from Eastern Michigan University in 2006. Mr. Wiggin is working on improving the lab's information aquisition, processing and storage by developing custom applications and providing consulting about existing tools. He also acts as a facilitator between biologically and computationally oriented groups to help increase the productivity of those relationships.

 

June A. Wilson
Executive Assistant

Wilson

June Wilson is executive assistant to Dr. Feldman and Marty Fischhoff for the Taubman Institute, as well as supporting members of Dr. Feldman’s neurology program. She is responsible for grant submissions, daily correspondence and administrative activities for the Institute. Prior to working for the Institute, June was a member of the Department of Ophthalmology and Visual Sciences at the University of Michigan as the grants/contracts assistant, as well as working in the laboratory of Debra A. Thompson, Ph.D.   June received her Bachelor of Science in biology from Southampton College, Long Island University.